171 related articles for article (PubMed ID: 22959517)
1. Synthesis and SAR of 2',3'-bis-O-substituted N(6), 5'-bis-ureidoadenosine derivatives: implications for prodrug delivery and mechanism of action.
Shelton JR; Cutler CE; Browning MS; Balzarini J; Peterson MA
Bioorg Med Chem Lett; 2012 Oct; 22(19):6067-71. PubMed ID: 22959517
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, SAR, and preliminary mechanistic evaluation of novel antiproliferative N⁶,5'-bis-ureido- and 5'-carbamoyl-N⁶-ureidoadenosine derivatives.
Shelton JR; Cutler CE; Oliveira M; Balzarini J; Peterson MA
Bioorg Med Chem; 2012 Jan; 20(2):1008-19. PubMed ID: 22189274
[TBL] [Abstract][Full Text] [Related]
3. Preliminary SAR analysis of novel antiproliferative N(6),5'-bis-ureidoadenosine derivatives.
Peterson MA; Oliveira M; Christiansen MA; Cutler CE
Bioorg Med Chem Lett; 2009 Dec; 19(23):6775-9. PubMed ID: 19850476
[TBL] [Abstract][Full Text] [Related]
4. A broad spectrum anticancer nucleoside with selective toxicity against human colon cells in vitro.
Shelton JR; Burt SR; Peterson MA
Bioorg Med Chem Lett; 2011 Mar; 21(5):1484-7. PubMed ID: 21288718
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a nanomolar inhibitor of lung adenocarcinoma in vitro.
Shelton JR; Balzarini J; Peterson MA
Bioorg Med Chem Lett; 2014 Nov; 24(21):5107-10. PubMed ID: 25262542
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo.
Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR
Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activity of 5'-deoxy-4'-thio-L-nucleosides.
Cong L; Zhou W; Jin D; Wang J; Chen X
Chem Biol Drug Des; 2010 Jun; 75(6):619-27. PubMed ID: 20337785
[TBL] [Abstract][Full Text] [Related]
8. Antineoplastic agents. 578. Synthesis of stilstatins 1 and 2 and their water-soluble prodrugs.
Pettit GR; Thornhill A; Melody N; Knight JC
J Nat Prod; 2009 Mar; 72(3):380-8. PubMed ID: 19228038
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of N-acylamino acids derivatives of triazenes. Activation by tyrosinase in human melanoma cell lines.
Monteiro AS; Almeida J; Cabral G; Severino P; Videira PA; Sousa A; Nunes R; Pereira JD; Francisco AP; Perry MJ; Mendes E
Eur J Med Chem; 2013; 70():1-9. PubMed ID: 24125877
[TBL] [Abstract][Full Text] [Related]
10. 3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 2. Effect of pyrrole-C2 and/or -C4 substitutions on biological activity.
Mai A; Massa S; Cerbara I; Valente S; Ragno R; Bottoni P; Scatena R; Loidl P; Brosch G
J Med Chem; 2004 Feb; 47(5):1098-109. PubMed ID: 14971890
[TBL] [Abstract][Full Text] [Related]
11. Aziridinyldinitrobenzamides: synthesis and structure-activity relationships for activation by E. coli nitroreductase.
Helsby NA; Atwell GJ; Yang S; Palmer BD; Anderson RF; Pullen SM; Ferry DM; Hogg A; Wilson WR; Denny WA
J Med Chem; 2004 Jun; 47(12):3295-307. PubMed ID: 15163209
[TBL] [Abstract][Full Text] [Related]
12. Structure-cytotoxicity relationship in a series of N-phosphorus substituted E,E-3,5-bis(3-pyridinylmethylene)- and E,E-3,5-bis(4-pyridinylmethylene)piperid-4-ones.
Leonova ES; Makarov MV; Rybalkina EY; Nayani SL; Tongwa P; Fonari A; Timofeeva TV; Odinets IL
Eur J Med Chem; 2010 Dec; 45(12):5926-34. PubMed ID: 21035234
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives.
Lan P; Wang J; Zhang DM; Shu C; Cao HH; Sun PH; Wu XM; Ye WC; Chen WM
Eur J Med Chem; 2011 Jun; 46(6):2490-502. PubMed ID: 21496972
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of 6H-isoindolo[2,1-a]indol-6-ones, analogues of batracylin, and related compounds.
Guillaumel J; Léonce S; Pierré A; Renard P; Pfeiffer B; Arimondo PB; Monneret C
Eur J Med Chem; 2006 Mar; 41(3):379-86. PubMed ID: 16442188
[TBL] [Abstract][Full Text] [Related]
15. Significant differences in biological parameters between prodrugs cleavable by carboxypeptidase G2 that generate 3,5-difluoro-phenol and -aniline nitrogen mustards in gene-directed enzyme prodrug therapy systems.
Niculescu-Duvaz I; Scanlon I; Niculescu-Duvaz D; Friedlos F; Martin J; Marais R; Springer CJ
J Med Chem; 2004 May; 47(10):2651-8. PubMed ID: 15115406
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia activated prodrugs of a 9-aza-anthrapyrazole derivative that has promising anticancer activity.
El-Dakdouki MH; Adamski N; Foster L; Hacker MP; Erhardt PW
J Med Chem; 2011 Dec; 54(23):8224-7. PubMed ID: 22011244
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and cytostatic activity of purine nucleosides derivatives of allofuranose.
Besada P; Costas T; Teijeira M; Terán C
Eur J Med Chem; 2010 Dec; 45(12):6114-9. PubMed ID: 20934790
[TBL] [Abstract][Full Text] [Related]
18. Novel cyclopropapyrroloindole derivative (AT-3510) bearing methoxycarbonyl and trifluoromethyl groups.
Fukuda Y; Furuta H; Kusama Y; Ebisu H; Oomori Y; Terashima S
J Med Chem; 1999 Apr; 42(8):1448-58. PubMed ID: 10212131
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel beta-carbolines with efficient DNA-binding capacity and potent cytotoxicity.
Chen Z; Cao R; Shi B; Yi W; Yu L; Song H; Ren Z; Peng W
Bioorg Med Chem Lett; 2010 Jul; 20(13):3876-9. PubMed ID: 20627721
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of C-methyl-beta-D-ribofuranosyladenine nucleoside ribonucleotide reductase inhibitors.
Franchetti P; Cappellacci L; Pasqualini M; Petrelli R; Vita P; Jayaram HN; Horvath Z; Szekeres T; Grifantini M
J Med Chem; 2005 Jul; 48(15):4983-9. PubMed ID: 16033277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
